A CLINICAL STUDY OF BENIGN BREAST DISEASE IN A PRIMARY HEALTH CARE CENTRE
Main Article Content
Keywords
benign breast disease, fibroadenoma, triple assessment, breast pain or mastalgia, fibro adenosis .
Abstract
Background
Benign breast diseases (BBD) encompass a wide spectrum of non-malignant conditions of the breast. Accurate clinicopathological evaluation is crucial for differentiating BBD from malignant lesions, guiding appropriate management, and reducing patient anxiety. Triple assessment, which includes clinical examination, imaging and histopathological examination is now considered as a gold standard approach to diagnosis of breast lump. This study aims to evaluate the clinical presentations, incidence of benign breast disease and its different types.
Method
A cross- sectional, observational study of 184 female patients who attended primary health care center, with various forms of breast disease during the period from January 2015 to December 2018, was conducted. A detailed history was taken from every patient, followed by clinical examination, imaging and cytological or histological examination (FNAC or core biopsy) in all the patients. All female patients aged 18 years and above presenting with breast complaints and diagnosed with BBD were included.
Results
In this study, fibroadenoma (55.3 %) was the commonest lesion seen in the age group of 21 -30 yrs., followed by fibro adenosis (26.8 %). The commonest presentation was breast lump (82 %) followed by breast pain and nipple discharge. Breast pain or mastalgia was cyclical in majority of case.
ConclusionBBD is a heterogenous group of disease seen predominantly in female patients in the age group of 21- 30 yrs. Triple assessment remains the key in evaluation of breast lumps. Fibroadenoma is the most common BBD seen. Appropriate counselling and treatment can go a long way in reducing patient’s anxiety associated with benign breast disease.
References
2. Hughes LE, Mansel RE, Webster DJT. The approach to diagnosis and assessment of benign breast lumps benign disorders and diseases of the breast concepts and clinical management, 2ndedition. London: WB Saunders; 2005:35.
3. Dahri FJ, Awan MS, Leghari AA, Khaskheli NM, Soomro I, Memon ZI. An early diagnosis of benign breast diseases J Surg Pak Int. 2010;15(4):186
4. Kelsey JL, Gammon MD. Epidemiology of breast cancer. Epidemiol Rev.1990;12:228-40.
5. Cole P, Mark Elwood J, Kaplan SD. Incidence rates and risk factors of benign breast neoplasms. Am J Epidemiol.1978;108:112-20.
6. Utchinson WB, Thomas DB, Hamlin WB. Risk of breast cancer in women with benign breast lesion. J Natl Cancer Inst.1980;65:13-20.
7. Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. ArchPathol Lab Med. 1998;122:1053-55.
8. Sarnelli R, Squartini F. Fibrocystic condition and at risk lesions in asymptomatic breasts: a morphologic study of postmenopausal women. Clin Exp Obstet Gynecol. 1991;18:271-9.
9. Bartow SA, Pathak DR, Black WC.Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer.1987;60:2751-60.
10. Cook MG, Rohan TE. The Patho-epidemiology of benign proliferative epithelial disorders of the female breast. J Pathol.1985;146:1-15.
11. Vecchia C, Parazzini F, Franceschi S. Risk factors for benign breast disease and their relation with breast cancer risk. Pooled information from epidemiologic studies. Tumori.1985;71:167-78.
12. Mansel RE. European multicentre trial of Bromocriptine in cyclic mastalgia. Lancet. 1990;335:190-92.
13. Koorapati R, Kishan B. A study on clinical and pathological correlation of benign breast lesions. Int Surg J 2017;4:2700–5.
14. Pudale S, Tonape DS. A histopathological study of non-malignant breast lesions. Int J Res Med Sci 2015;3:2672–6.]
15. Boral S, Jagtap SV. Clinicohistopathological study of benign breast lesions in surgically excised specimens in a tertiary care hospital. J Cancer Res Ther. 2023 Apr;19(Supplement):S116-S120. doi: 10.4103/jcrt.JCRT_688_20. PMID: 37147991.
16. Sangma MB, Panda K, Dasiah S. A clinico-pathological study on benign breast diseases. J Clin Diagn Res 2013;7:503–6.
17. Jabbo NS, Jassim HA. Pattern of benign female breast disease in Al-Yarmouk Teaching Hospital. MMJ 2010;9:21–4.]
18. Krishnaswamy U. profile of benign breast disease in urban India Indian J Surg. 2003;65:178-81
19. Selvakumaran S, Sangma Mimamaychet B. Study of benign breast disease Int Surg J. 2017 ; 4:339-43
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Siddhartha Buragohain
Assistant Professor, Dept of Obstetrics & Gynaecology, Jorhat Medical College & Hospital, Jorhat, Assam, India.
Dr. Pompi Daimari Buragohain
Consultant Surgeon, Mission Hospital, Jorhat, Assam, India.